Sign in Pull a receipt

ARWR

ARROWHEAD PHARMACEUTICALS, INC.

Healthcare · Biotechnology

$40.80 sample

-0.26 (-0.63%) 1D

Market cap

$222.3B

Price as of

2026-10-24

Latest filing

8-K

Alerts

8

Price$40.80 +0.12% 3M daily closessample

44.7240.30

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20INSInsider sell: Chief Financial Officer
Oct 13INSInsider buy: Chief Executive Officer
Oct 08INSInsider buy: General Counsel
Oct 02INSInsider sell: Chief Executive Officer
Sep 25INSInsider sell: Chief Financial Officer
Sep 17INSInsider sell: EVP, Operations
Sep 14INSInsider sell: EVP, Operations
Sep 09INSInsider sell: 10% owner

Sign up to see the real ARWR record →

Company facts

SEC EDGAR registration

Name: ARROWHEAD PHARMACEUTICALS, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +14sample, -100 to +100
Reporting currency: USD

Who is positioning in ARWR

sample

Insiders: 16 insider transactions over 90 days, net selling, $689.1M
Congress: 3 members traded over 90 days
Institutions · 13F: 30 funds hold $3.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$10.7B +22.6% y/y

Q4 2024Q3 2026

Inventory$6.5B +21.0% y/y

Q4 2024Q3 2026

Accounts receivable$4.7B +12.2% y/y

Q4 2024Q3 2026

Total debt$12.9B +20.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $147.4B +12.5% 3M
Sample peer B: $30.2B +9.8% 3M
Sample peer C: $131.3B -7.5% 3M
Sample peer D: $69.7B +9.7% 3M
Sample peer E: $158.6B +4.0% 3M